Due to the lack of data on the molecular characteristics of CRC (including MSI, CIMP, and BRAF/KRAS mutation status) in Chinese populations, we sought to utilise a population-based CRC cohort to more accurately determine the prevalence and characteristics of these features in a Chinese CRC population. The gene discussed is KRAS; the disease is colorectal carcinoma.